TY - JOUR
T1 - Healthcare utilisation among cancer survivors over 50 years of age
AU - Coughlan, D.
AU - Doherty, E.
AU - Frick, K.
AU - Ward, P.
AU - O’Neill, C.
N1 - Publisher Copyright:
© 2016, Irish Medical Association. All rights reserved.
PY - 2016/2
Y1 - 2016/2
N2 - There are now over 104,000 people living in Ireland with a cancer diagnosis. Using The Irish Longitudinal Study on Ageing (TILDA), healthcare utilisation of cancer survivors (aged 50 +) was compared with those without a history of cancer across service providers. Our cancer variable was stratified by time since diagnosis (2-5, 6-10, 11+ years) and type (breast, prostate, colorectal and a miscellaneous group of ‘other’ cancers). While the probability of cancer survivors accessing GP services was not significant different to respondents without a history of cancer, the probability of an outpatient specialist office visit was 19.5, 11.8 and 14.0 percentage points higher, respectively for those 2-5years, 6-10 years and 11 years or more after their cancer diagnosis and was statistically significant. In Ireland, the pattern of GP and specialist use appears less well defined compared to other European countries. This suggests an overarching policy response is required for cancer survivorship care.
AB - There are now over 104,000 people living in Ireland with a cancer diagnosis. Using The Irish Longitudinal Study on Ageing (TILDA), healthcare utilisation of cancer survivors (aged 50 +) was compared with those without a history of cancer across service providers. Our cancer variable was stratified by time since diagnosis (2-5, 6-10, 11+ years) and type (breast, prostate, colorectal and a miscellaneous group of ‘other’ cancers). While the probability of cancer survivors accessing GP services was not significant different to respondents without a history of cancer, the probability of an outpatient specialist office visit was 19.5, 11.8 and 14.0 percentage points higher, respectively for those 2-5years, 6-10 years and 11 years or more after their cancer diagnosis and was statistically significant. In Ireland, the pattern of GP and specialist use appears less well defined compared to other European countries. This suggests an overarching policy response is required for cancer survivorship care.
UR - http://www.scopus.com/inward/record.url?scp=84964078836&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:84964078836
SN - 0332-3102
VL - 109
SP - 359
JO - Irish Medical Journal
JF - Irish Medical Journal
IS - 2
ER -